MARKSANS PHARMA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Marksans Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.41₹ -0.75
As on Oct 31, 2025, 4:01 PM IST
Marksans Pharma Price Performance
Today's LowToday's High
₹181.00₹185.50
₹182.80
52 Weeks' Low52 Weeks' High
₹162.05₹358.50
₹182.80
Open Price
₹183.55
Prev. Close
₹183.55
Volume
62,490
Over the last 5 years, the share price of Marksans Pharma has gained 29.01% CAGR. Over the past year, the corresponding return has been -36.86%.
Marksans Pharma’s current P/E of 23.66x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Marksans Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Marksans Pharma | 3.34 | 9.69 | -19.75 | -18.25 | -36.86 | 54.67 | 29.01 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Marksans Pharma has declined 36.86% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Marksans Pharma has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Marksans Pharma Financials
Marksans Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 179.31 | 181.87 |
| 10 | 178.99 | 179.98 |
| 20 | 173.84 | 177.73 |
| 50 | 174.19 | 182.73 |
| 100 | 208.64 | 197.41 |
| 200 | 220.51 | 212.33 |
Marksans Pharma Share Holding Pattern
In the latest quarter, Marksans Pharma remained same as its previous close in promoter holding, while DII stake decreased to 5.28%, FII holding fell to 16.92%, and public shareholding moved up to 33.93% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Marksans Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 21,59,816 | 0.56 | 35.65 | |
| 20,19,995 | 0.67 | 33.34 | |
| 7,55,000 | 1.14 | 12.46 | |
| 7,01,714 | 0.25 | 11.58 |
* Excluding Index & Arbitrage Funds
Marksans Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 31, 2025, 5:11 PM IST | Marksans Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 27, 2025, 3:53 PM IST | Marksans Pharma - ESG Score By CFC Finlease Private Limited (Voluntary) |
| Oct 23, 2025, 10:30 PM IST | Marksans Pharma - Board Meeting Intimation for Declaration Of Quarterly Results For The Quarter And Nine Months Ended Septemb |
| Oct 15, 2025, 7:24 PM IST | Marksans Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Oct 13, 2025, 5:03 PM IST | Marksans Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About Marksans Pharma
Marksans Pharma Ltd. is a Public Limited Listed company incorporated on 16/04/1992 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24110MH1992PLC066364 and registration number is 066364. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1174.37 Cr. and Equity Capital is Rs. 45.32 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address11th Floor, Grandeur, Veera Desai Extension Road, Mumbai Maharashtra 400053
- Contact
Management
- Mr. Mark SaldanhaChairman & Managing Director
- Mrs. Sandra SaldanhaWhole Time Director
- Mr. Varddhman V JainWhole Time Director
- Dr. Sunny SharmaNon Executive Director
- Mr. Srinivas MishraIndependent Director
- Mr. Digant Mahesh ParikhIndependent Director
- Mr. Abhinna Sundar MohantyIndependent Director
- Mrs. Shailaja VardhanIndependent Director
FAQs on Marksans Pharma Share Price
What is the share price of Marksans Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Marksans Pharma is ₹182.80 as on Oct 31, 2025.
What kind of stock is Marksans Pharma?
The Marksans Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Marksans Pharma?
The market cap of Marksans Pharma is ₹8,283.83 Cr as on Oct 31, 2025.
What are today's High and Low prices of Marksans Pharma?
Today’s highest and lowest price of Marksans Pharma are ₹185.50 and ₹181.00.
What are the 52 Week High and 52 Week Low of Marksans Pharma?
The 52-week high/low is the highest and lowest price at which Marksans Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Marksans Pharma is ₹358.50 and 52-week low of Marksans Pharma is ₹162.05 as on Oct 31, 2025.
How has the Marksans Pharma performed historically in terms of returns?
The Marksans Pharma has shown returns of -0.41% over the past day, 9.69% for the past month, -19.75% over 3 months, -36.86% over 1 year, 54.67% across 3 years, and 29.01% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Marksans Pharma?
P/E ratio of and PB ratio of Marksans Pharma are 23.66 and 3.63 on Oct 31, 2025. While the company gives a dividend yield of 0.44 per annum.
Marksans Pharma News
✕
Market Pulse